Trials / Completed
CompletedNCT01525797
Blood Draw Study for Liver Transplant Patients
Immunomonitoring of Transplant Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 221 (actual)
- Sponsor
- Baylor Research Institute · Academic / Other
- Sex
- All
- Age
- 17 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.
Detailed description
The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.
Conditions
Timeline
- Start date
- 2002-10-15
- Primary completion
- 2013-10-04
- Completion
- 2013-10-04
- First posted
- 2012-02-03
- Last updated
- 2026-01-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01525797. Inclusion in this directory is not an endorsement.